Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 09-Mar-23 9:29 PM View:  | Hodits Regina Director | Carisma Therapeutics Inc. (CARM) | 07-Mar-23 | Grant | 2,297,550 | -- | -- | 100% 0 to 2.3M | |
| 09-Mar-23 10:00 PM View: | Zweifach Sanford S Director | Carisma Therapeutics Inc. (CARM) | 07-Mar-23 | Grant | 413 | -- | -- | 100% 0 to 0.41K | |
| 09-Mar-23 9:25 PM View: | Torok Michael Director | Carisma Therapeutics Inc. (CARM) | 07-Mar-23 | Grant | 51,250 | -- | -- | 100% 0 to 51.25K | |
| 09-Mar-23 9:31 PM View: | Ugwumba Chidozie Director | Carisma Therapeutics Inc. (CARM) | 07-Mar-23 | Grant | 2,215,880 | -- | -- | 100% 0 to 2.22M | |
| 09-Mar-23 10:00 PM View: | Klichinsky Michael Chief Scientific Officer | Carisma Therapeutics Inc. (CARM) | 07-Mar-23 | Grant | 484,347 | -- | -- | 100% 0 to 484.35K | |
| 09-Mar-23 9:25 PM View: | Torok Michael Director | Carisma Therapeutics Inc. (CARM) | 07-Mar-23 | Grant | 369,991 | -- | -- | 722% 51.25K to 421.24K | |
| 09-Mar-23 10:00 PM View: | Morrison Briggs Director | Carisma Therapeutics Inc. (CARM) | 07-Mar-23 | Grant | 12,175 | -- | -- | 100% 0 to 12.18K | |
| 06-Mar-23 8:43 PM View: | Cannell Thomas R President and CEO Director | Carisma Therapeutics Inc. (CARM) | 02-Mar-23 | Option Sale | 487,487 | $0.59 | $286,155.00 | (42%) 1.16M to 672.39K | |
| 06-Mar-23 8:46 PM View: | Sullivan Mark General Counsel & Secretary | Carisma Therapeutics Inc. (CARM) | 02-Mar-23 | Option Exercise | 298,175 | $0.59 | $175,029.00 | 99% 299.69K to 597.87K | |
| 06-Mar-23 8:41 PM View: | Forbes Monica Chief Financial Officer | Carisma Therapeutics Inc. (CARM) | 02-Mar-23 | Option Sale | 345,849 | $0.59 | $203,013.00 | (41%) 851.51K to 505.66K | |
| 06-Mar-23 8:44 PM View: | Ryu Elly Principal Accounting Officer | Carisma Therapeutics Inc. (CARM) | 02-Mar-23 | Sale | 17,289 | $0.59 | $10,148.60 | (10%) 165.91K to 148.62K | |
| 06-Mar-23 8:43 PM View: | Cannell Thomas R President and CEO Director | Carisma Therapeutics Inc. (CARM) | 02-Mar-23 | Option Exercise | 606,800 | $0.59 | $356,192.00 | 110% 553.07K to 1.16M | |
| 06-Mar-23 8:45 PM View: | MacDonald Glen C Chief Technology Officer | Carisma Therapeutics Inc. (CARM) | 02-Mar-23 | Option Sale | 170,372 | $0.59 | $100,008.00 | (30%) 569.29K to 398.92K | |
| 06-Mar-23 8:41 PM View: | Forbes Monica Chief Financial Officer | Carisma Therapeutics Inc. (CARM) | 02-Mar-23 | Option Exercise | 371,125 | $0.59 | $217,850.00 | 77% 480.39K to 851.51K | |
| 06-Mar-23 8:45 PM View: | MacDonald Glen C Chief Technology Officer | Carisma Therapeutics Inc. (CARM) | 02-Mar-23 | Option Exercise | 286,292 | $0.59 | $168,053.00 | 101% 283.0K to 569.29K | |
| 06-Mar-23 8:46 PM View: | Sullivan Mark General Counsel & Secretary | Carisma Therapeutics Inc. (CARM) | 02-Mar-23 | Option Sale | 219,218 | $0.59 | $128,681.00 | (37%) 597.87K to 378.65K | |
| 23-Feb-23 7:36 PM View: | Ryu Elly Principal Accounting Officer | Carisma Therapeutics Inc. (CARM) | 21-Feb-23 | Sale | 7,159 | $0.59 | $4,204.48 | (4%) 173.07K to 165.91K | |
| 23-Feb-23 7:31 PM View: | MacDonald Glen C Chief Technology Officer | Carisma Therapeutics Inc. (CARM) | 21-Feb-23 | Sale | 25,927 | $0.59 | $15,226.90 | (8%) 308.93K to 283.0K | |
| 23-Feb-23 7:38 PM View: | Sullivan Mark General Counsel & Secretary | Carisma Therapeutics Inc. (CARM) | 21-Feb-23 | Sale | 39,831 | $0.59 | $23,392.70 | (12%) 339.52K to 299.69K | |
| 23-Feb-23 7:35 PM View: | Cannell Thomas R President and CEO Director | Carisma Therapeutics Inc. (CARM) | 21-Feb-23 | Sale | 53,727 | $0.59 | $31,553.90 | (9%) 606.8K to 553.07K | |
| 23-Feb-23 7:33 PM View: | Forbes Monica Chief Financial Officer | Carisma Therapeutics Inc. (CARM) | 21-Feb-23 | Sale | 61,862 | $0.59 | $36,331.60 | (11%) 542.25K to 480.39K | |
| 24-Jun-22 6:29 PM View: | Keyes Jason A Director | Carisma Therapeutics Inc. (CARM) | 22-Jun-22 | Grant | 40,000 | -- | -- | 100% 0 to 40.0K | |
| 24-Jun-22 6:30 PM View: | Jewett Michael A. S. Director | Carisma Therapeutics Inc. (CARM) | 22-Jun-22 | Grant | 40,000 | -- | -- | 100% 0 to 40.0K | |
| 24-Jun-22 6:37 PM View: | Duker Jay S. Director | Carisma Therapeutics Inc. (CARM) | 22-Jun-22 | Grant | 40,000 | -- | -- | 100% 0 to 40.0K | |
| 24-Jun-22 6:28 PM View: | Bourdow Carrie L. Director | Carisma Therapeutics Inc. (CARM) | 22-Jun-22 | Grant | 40,000 | -- | -- | 100% 0 to 40.0K | |
| 24-Jun-22 6:31 PM View: | Honig Peter Director | Carisma Therapeutics Inc. (CARM) | 22-Jun-22 | Grant | 40,000 | -- | -- | 100% 0 to 40.0K | |
| 23-Feb-22 8:36 PM View: | Cannell Thomas R President and CEO Director | Carisma Therapeutics Inc. (CARM) | 18-Feb-22 | Grant | 606,800 | -- | -- | 100% 0 to 606.8K | |
| 23-Feb-22 8:34 PM View: | Forbes Monica Chief Financial Officer | Carisma Therapeutics Inc. (CARM) | 18-Feb-22 | Grant | 542,250 | -- | -- | 100% 0 to 542.25K | |
| 23-Feb-22 8:33 PM View: | MacDonald Glen C Chief Technology Officer | Carisma Therapeutics Inc. (CARM) | 18-Feb-22 | Grant | 308,925 | -- | -- | 100% 0 to 308.93K | |
| 23-Feb-22 8:37 PM View: | Ryu Elly Principal Accounting Officer | Carisma Therapeutics Inc. (CARM) | 18-Feb-22 | Grant | 86,300 | -- | -- | 100% 0 to 86.3K | |
| 23-Feb-22 8:37 PM View: | Sullivan Mark General Counsel & Secretary | Carisma Therapeutics Inc. (CARM) | 18-Feb-22 | Grant | 339,525 | -- | -- | 100% 0 to 339.52K | |
| 04-Oct-21 7:29 PM View: | Ryu Elly Principal Accounting Officer | Carisma Therapeutics Inc. (CARM) | 01-Oct-21 | Grant | 115,000 | -- | -- | 983% 11.7K to 126.7K | |
| 16-Feb-17 5:09 PM View: | McCabe John J Chief Financial Officer | Carisma Therapeutics Inc. (CARM) | 14-Feb-17 | Market Sale | 1,399 | $2.10 | $2,937.90 | (19%) 7.33K to 5.93K | 40% |
| 30-Sep-16 4:12 PM View: | Celniker Abbie Director | Carisma Therapeutics Inc. (CARM) | 28-Sep-16 | Market Sale | 10,031 | $3.00 | $30,093.00 | (2%) 419.95K to 409.92K | 61% |
| 26-Sep-16 4:03 PM View: | Flagship Ventures Fund Iv, ... 10% Owner | Carisma Therapeutics Inc. (CARM) | 23-Sep-16 | Market Sale | 67,071 | $3.11 | $208,856.00 | (3%) 2.43M to 2.37M | 62% |
| 26-Sep-16 4:03 PM View: | Flagship Ventures Fund Iv, ... 10% Owner | Carisma Therapeutics Inc. (CARM) | 22-Sep-16 | Market Sale | 376,351 | $3.17 | $1,194,440.00 | (13%) 2.81M to 2.43M | 63% |
| 21-Sep-16 5:37 PM View: | Flagship Ventures Fund Iv, ... 10% Owner | Carisma Therapeutics Inc. (CARM) | 21-Sep-16 | Market Sale | 322,723 | $3.75 | $1,210,210.00 | (10%) 3.13M to 2.81M | 69% |
| 22-Sep-16 4:54 PM View: | Hurly Stephen A President and CEO Director | Carisma Therapeutics Inc. (CARM) | 20-Sep-16 | Grant | 398,031 | -- | -- | 100% 0 to 398.03K | |
| 21-Sep-16 5:37 PM View: | Flagship Ventures Fund Iv, ... 10% Owner | Carisma Therapeutics Inc. (CARM) | 20-Sep-16 | Market Sale | 53,917 | $3.39 | $182,779.00 | (2%) 3.19M to 3.13M | 65% |
| 22-Sep-16 5:04 PM View: | Dan Leslie Director 10% Owner | Carisma Therapeutics Inc. (CARM) | 20-Sep-16 | Grant | 3,582,330 | -- | -- | 100% 0 to 3.58M | |
| 21-Sep-16 5:37 PM View: | Flagship Ventures Fund Iv, ... 10% Owner | Carisma Therapeutics Inc. (CARM) | 19-Sep-16 | Market Sale | 9,700 | $3.31 | $32,107.00 | (< 1%) 3.2M to 3.19M | 64% |
| 16-Sep-16 4:15 PM View: | Flagship Ventures Fund Iv, ... 10% Owner | Carisma Therapeutics Inc. (CARM) | 15-Sep-16 | Market Sale | 2,681 | $4.16 | $11,153.00 | (< 1%) 3.2M to 3.2M | 72% |
| 16-Sep-16 4:15 PM View: | Flagship Ventures Fund Iv, ... 10% Owner | Carisma Therapeutics Inc. (CARM) | 14-Sep-16 | Market Sale | 44,011 | $4.18 | $183,966.00 | (1%) 3.24M to 3.2M | 72% |
| 08-Sep-16 6:53 PM View: | Flagship Ventures Fund Iv, ... 10% Owner | Carisma Therapeutics Inc. (CARM) | 07-Sep-16 | Market Sale | 93,727 | $4.51 | $422,709.00 | (3%) 3.34M to 3.24M | 74% |
| 08-Sep-16 6:53 PM View: | Flagship Ventures Fund Iv, ... 10% Owner | Carisma Therapeutics Inc. (CARM) | 06-Sep-16 | Market Sale | 35,770 | $4.63 | $165,615.00 | (1%) 3.37M to 3.34M | 75% |
| 17-Aug-16 7:07 AM View: | McCabe John J Chief Financial Officer | Carisma Therapeutics Inc. (CARM) | 15-Aug-16 | Market Sale | 1,170 | $4.80 | $5,616.00 | (14%) 8.5K to 7.33K | 75% |
| 29-Jun-16 4:16 PM View: | Tubridy Karen L Chief Development Officer | Carisma Therapeutics Inc. (CARM) | 27-Jun-16 | Market Sale | 4,372 | $2.08 | $9,093.76 | (12%) 37.13K to 32.75K | 43% |
| 29-Jun-16 4:14 PM View: | Celniker Abbie President and CEO Director | Carisma Therapeutics Inc. (CARM) | 27-Jun-16 | Market Sale | 10,029 | $2.08 | $20,860.30 | (2%) 429.98K to 419.95K | 43% |
| 14-Jun-16 5:24 PM View: | Boxer Capital, LLC 10% Owner | Carisma Therapeutics Inc. (CARM) | 13-Jun-16 | Market Sale | 1,042,000 | $2.74 | $2,859,350.00 | (38%) 2.73M to 1.69M | 57% |
| 17-Feb-16 5:04 PM View: | McCabe John J Senior Vice President, Finance | Carisma Therapeutics Inc. (CARM) | 16-Feb-16 | Market Sale | 1,501 | $0.27 | $405.27 | (15%) 10.0K to 8.5K | (331%) |
